Cargando…
Impact of CFTR modulator use on outcomes in people with severe cystic fibrosis lung disease
Drug compounds that augment the production and activity of the cystic fibrosis (CF) transmembrane regulator (CFTR) have revolutionised CF care. Many adults and some children with CF suffer advanced and severe lung disease or await lung transplantation. While the hope is that these drug compounds wil...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Respiratory Society
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488599/ https://www.ncbi.nlm.nih.gov/pubmed/32198216 http://dx.doi.org/10.1183/16000617.0112-2019 |